logo
ProjectEnded

many(Anti)Bodies

Ended · Sweden

Source: EU Funding & Tenders Portal

Many of the exceptional breakthroughs in pharmaceutics require the collective and interdisciplinary effort of the scientific community to overcome challenges and shortcomings involved in optimizing the formulation of the final product. Monoclonal antibodies, for instance, have been found to be highly effective for the treatment of various immunological and allergic diseases as well as for cancer t

Status
Closed
Location
Sweden
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about many(Anti)Bodies

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “many(Anti)Bodies” is an infrastructure initiative, located in Sweden. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Many of the exceptional breakthroughs in pharmaceutics require the collective and interdisciplinary effort of the scientific community to overcome challenges and shortcomings involved in optimizing the formulation of the final product. Monoclonal antibodies, for instance, have been found to be highly effective for the treatment of various immunological and allergic diseases as well as for cancer treatments thanks to their high specificity. On the other hand, they typically present high viscosities in concentrated solutions, dramatically altering their flow properties. The direct consequence is the difficulty in preparing stable solutions suitable for subcutaneous self-administration which, compared to intravenous infusion, would be advantageous in terms of patient compliance and adherence to the treatment, and reduced healthcare costs. Currently, a univocal framework providing microscopic interpretation to the enhanced viscosity is missing. With my proposal many(Anti)Bodies, I aim to address this issue by putting forward an interdisciplinary approach which exploits soft matter and colloidal science to investigate the molecular origin of the observed macroscopic behavior in antibody solutions. By combining numerical simulations with experiments, I will first design an accurate single-molecule model that accounts for the anisotropic shape of the antibody and include all relevant ingredients that determine intermolecular interactions. Therefore, through advanced computational techniques, I will be able to bring the current understanding of the antibody collective behavior and rheological properties to a new level, by shedding light on their dynamics and self-association in crowded environments. With the direct collaboration of pharmaceutical industries, my proposal will ultimately guide the formulation of novel antibody-based biologics and inspire future studies where the features of the antibody are designed according to the desired solution properties.

Location

Country

Sweden

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Article published date

2025-12-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project